Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 14, 2025

Quantifying Immune Checkpoint engagement in Patient Biopsies

View Full Paper
Ask AI
Bookmark
Share

Authors

CNClaudia NavasLCL.M. CamachoJAJ.M. Ferrer Agüero

Discussion

Loading...

Member takes

Overview

Quantitative profiling identifies biomarkers linking immune checkpoint blockade effectiveness and patient outcomes, suggesting more tailored immunotherapy.

Key Points

  • Main finding shows that current biomarkers like PD-L1 TPS score are inadequate for patient stratification.
  • Strong evidence indicates that a quantitative spatial proteomics approach could enhance understanding of immune interactions in tumours.
  • The analysis involved assessing immune checkpoints in patient tissue samples to determine their functional state.
  • Significance lies in the potential for improved immunotherapy strategies by targeting specific patient needs based on immune profiling.

Cite This Study

Navas et al. (2025) studied this question.

synapsesocial.com/papers/689a02b6e6551bb0af8cc42dhttps://doi.org/10.1101/2025.07.04.25330865
View Full Paper
Ask AI
Bookmark
Share